11.01.2016, 08:34
LifeWatch AG: Agreement with AliveCor, Inc.
OREANDA-NEWS. LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, is pleased to announce the signing of an agreement with AliveCor Inc. to utilize the AliveCor(R) Mobile ECG technology in its cardiac monitoring business. We are working together to integrate the AliveCor Mobile ECG into LifeWatch's cardiac monitoring product offering.
Dr. Stephan Rietiker, CEO of LifeWatch, commented, "Digital health monitoring is revolutionizing how people interact with healthcare delivery. The AliveCor Mobile ECG will enable LifeWatch to broaden its cardiac event monitoring services, whilst at the same time opening the door to post-event cardiac monitoring via a patient's own mobile device. This will provide the patient with greater control and convenience. At the same time, physicians will benefit from a broader range of attractive, diagnostic options. AliveCor's technology offering complements that of LifeWatch, and emphasizes our commitment to using the most innovative technologies available."
"We are excited about expanding into the remote patient monitoring market, which will allow us to have a bigger impact on people's lives and bring healthcare into the 21st century," said Vic Gundotra, chief executive officer of AliveCor. "Using the AliveCor Mobile ECG will keep patients in touch with their physicians outside of the hospital and can help to identify cardiac problems before something life-threatening occurs."
The AliveCor Mobile ECG records accurate ECGs and heart rate anywhere and at any time. The customer simply rests the fingers on the device or places the device to the chest to record an ECG in just 30 seconds. A first response is provided immediately with an in-depth expert analysis available as required.
About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products.
About AliveCor, Inc.
AliveCor Inc., is recognized around the world for transforming cardiac care. The FDA cleared AliveCor(R) Mobile ECG is the most clinically validated mobile ECG monitor on the market. It is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. Today, we offer a simple to use mobile device and service providing instant analysis for detecting atrial fibrillation (AFib) and normal ECG's. AliveCor is a privately-held company headquartered in San Francisco, Calif.
Dr. Stephan Rietiker, CEO of LifeWatch, commented, "Digital health monitoring is revolutionizing how people interact with healthcare delivery. The AliveCor Mobile ECG will enable LifeWatch to broaden its cardiac event monitoring services, whilst at the same time opening the door to post-event cardiac monitoring via a patient's own mobile device. This will provide the patient with greater control and convenience. At the same time, physicians will benefit from a broader range of attractive, diagnostic options. AliveCor's technology offering complements that of LifeWatch, and emphasizes our commitment to using the most innovative technologies available."
"We are excited about expanding into the remote patient monitoring market, which will allow us to have a bigger impact on people's lives and bring healthcare into the 21st century," said Vic Gundotra, chief executive officer of AliveCor. "Using the AliveCor Mobile ECG will keep patients in touch with their physicians outside of the hospital and can help to identify cardiac problems before something life-threatening occurs."
The AliveCor Mobile ECG records accurate ECGs and heart rate anywhere and at any time. The customer simply rests the fingers on the device or places the device to the chest to record an ECG in just 30 seconds. A first response is provided immediately with an in-depth expert analysis available as required.
About LifeWatch AG:
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products.
About AliveCor, Inc.
AliveCor Inc., is recognized around the world for transforming cardiac care. The FDA cleared AliveCor(R) Mobile ECG is the most clinically validated mobile ECG monitor on the market. It is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. Today, we offer a simple to use mobile device and service providing instant analysis for detecting atrial fibrillation (AFib) and normal ECG's. AliveCor is a privately-held company headquartered in San Francisco, Calif.
Комментарии